Genoway (ALGEN) - Total Liabilities

Latest as of June 2025: €20.43 Million EUR ≈ $23.89 Million USD

Based on the latest financial reports, Genoway (ALGEN) has total liabilities worth €20.43 Million EUR (≈ $23.89 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Genoway - Total Liabilities Trend (2004–2024)

This chart illustrates how Genoway's total liabilities have evolved over time, based on quarterly financial data. See ALGEN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Genoway Competitors by Total Liabilities

The table below lists competitors of Genoway ranked by their total liabilities.

Company	Country	Total Liabilities
Mount Logan Capital Inc. Common Stock NASDAQ:MLCI	USA	$1.49 Billion
Synel M.L.L Payway Ltd TA:SNEL	Israel	ILA56.81 Million
Battalion Oil Corp NYSE MKT:BATL	USA	$511.94 Million
Industrial Investment Trust Limited NSE:IITL	India	Rs41.98 Million
TINYBUILD REGSCAT3 DL-001 F:8Z3	Germany	€11.50 Million
Bellavista Resources Ltd AU:BVR	Australia	AU$244.21K
ERREDUE S.P.A. F:Z9H	Germany	€23.92 Million
Lisata Therapeutics Inc. NASDAQ:LSTA	USA	$4.64 Million

Liability Composition Analysis (2004–2024)

This chart breaks down Genoway's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Genoway.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.50	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genoway's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genoway (2004–2024)

The table below shows the annual total liabilities of Genoway from 2004 to 2024.

Year	Total Liabilities	Change
2024-12-31	€13.23 Million ≈ $15.46 Million	-8.54%
2023-12-31	€14.46 Million ≈ $16.90 Million	-13.71%
2022-12-31	€16.76 Million ≈ $19.59 Million	-6.59%
2021-12-31	€17.94 Million ≈ $20.97 Million	-3.40%
2020-12-31	€18.57 Million ≈ $21.71 Million	+50.86%
2019-12-31	€12.31 Million ≈ $14.39 Million	+4.35%
2018-12-31	€11.80 Million ≈ $13.79 Million	+18.25%
2017-12-31	€9.98 Million ≈ $11.66 Million	+54.90%
2016-12-31	€6.44 Million ≈ $7.53 Million	+5.62%
2015-12-31	€6.10 Million ≈ $7.13 Million	+16.59%
2014-12-31	€5.23 Million ≈ $6.12 Million	+12.63%
2013-12-31	€4.64 Million ≈ $5.43 Million	-18.53%
2012-12-31	€5.70 Million ≈ $6.66 Million	-1.31%
2011-12-31	€5.78 Million ≈ $6.75 Million	-15.47%
2010-12-31	€6.83 Million ≈ $7.99 Million	-6.98%
2009-12-31	€7.35 Million ≈ $8.59 Million	+7.59%
2008-12-31	€6.83 Million ≈ $7.98 Million	+19.20%
2007-12-31	€5.73 Million ≈ $6.70 Million	-17.87%
2006-12-31	€6.97 Million ≈ $8.15 Million	+16.76%
2005-12-31	€5.97 Million ≈ $6.98 Million	+69.98%
2004-12-31	€3.51 Million ≈ $4.11 Million	--

About Genoway

PA:ALGEN France Biotechnology

Market Cap

$33.90 Million

€29.00 Million EUR

Market Cap Rank

#23670 Global

#375 in France

Share Price

€2.35

Change (1 day)

-0.84%

52-Week Range

€2.10 - €3.45

All Time High

€5.54